Interleukin Genetics Reports Second Quarter 2009 Financi...(22841 57727 44341 Tota...)

Date:8/13/2009

22,841 57,727 44,341 Total operating costs and expenses 2,539,402 2,148,478 5,233,947 4,677,445 Loss from continuing operations (2,316,409) (1,626,859) (4,663,490) (3,513,954) Total other expense and income, net (34,401) 9,946 (58,239) 62,476 Net loss from continuing operations before income taxes (2,350,810) (1,616,913) (4,721,729) (3,451,478) Provision for income taxes 10,000 50 - (6,000) Net loss from continuing operations $(2,340,810)$(1,616,863) $(4,721,729)$(3,457,478) =========== =========== =========== =========== Net loss from discontinued operations (1,370,707) (49,482) (1,445,875) (83,969) Net Loss $(3,711,517)$(1,666,345) $(6,167,604)$(3,541,447) =========== =========== =========== =========== Net loss per basic and diluted common share from continuing operations $(0.07) $(0.05) $(0.14) $(0.11) ====== ====== ====== ====== Net loss per basic and diluted common share from discontinued operations $(0.05) $(0.00) $(0.05) $(0.00) ====== ====== ====== ====== Net loss per basic and diluted common share $(0.12) $(0.05) $(0.19) $(0.11) ====== ====== ====== ====== Weighted average common shares outstanding 32,010,387 30,976,909 31,933,612 30,904,916 ========== ========== ========== ==========

'/>"/>

SOURCE Interleukin Genetics, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related biology technology :

1. Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
2. Interleukin Genetics to Present at the 2009 BIO Business Forum
3. Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results
4. Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)
5. Interleukin Genetics Appoints Todd Anthony Walker as Vice President, Marketing
6. Interleukin Genetics Reports Third Quarter 2008 Financial Results
7. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
8. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
9. Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests
10. Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs
11. Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results